Control Bionics is excited to announce that NeuroNode® has been listed as a third-party assistive technology device on Apple’s website. Apple’s inclusion of the NeuroNode in its Apple-approved assistive technologies underscores NeuroNode’s versatility and effectiveness. Users can seamlessly integrate the NeuroNode with their Apple devices including iPads, iPhones, and computers, enhancing their ability to communicate and interact with the world around them.
NeuroNode is a groundbreaking wireless, wearable sensor that allows users to control their devices using bioelectric signals or spatial movements. This technology is particularly beneficial for individuals with paralysis and loss of speech including ALS / MND, spinal muscular atrophy, cerebral palsy, spinal cord injuries and more. NeuroNode is flexible and doesn’t require a specific body position or lighting conditions to activate.
By harnessing the body’s EMG signals or 3D spatial awareness, NeuroNode provides users with unprecedented control and independence.
This partnership between Control Bionics and Apple is a significant step forward in making advanced assistive technologies more accessible to those who need them. NeuroNode’s listing on Apple’s website makes it easier for people to discover NeuroNode, and gives users and clinicians the confidence that comes from recognition by Apple. As more people discover the life-changing benefits of the NeuroNode, we continue to see its growing adoption as an assistive technology.
